News

FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
On May 8, the Food and Drug Administration granted accelerated approval to the combination of avutometinib and defactinib for ...
This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson's disease - RMAT designation includes the benefits ...
The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.